Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q1- Text added to 2014 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Amblyomma, americanum, antiviral, applied, biopharmaceutical, bleeding, Bravecto, chewable, choose, Corrupt, criteria, doxorubicin, Elonva, EMA, evidentiary, fluralaner, folate, follicle, free, Gaynor, gel, HCl, hemorrhage, Hospira, Idenix, inclusion, infarction, Influenced, interference, intracranial, kill, label, led, liposomal, MAA, myocardial, nucleotide, objector, ophthalmology, overseeing, pathological, pegylated, pembrolizumab, peripheral, PLD, preservative, protocol, quickly, Racketeering, rapidly, rose, Saflutan, samatasvir, Santen, scientific, sterile, tafluprost, Taptiqom, temporarily, tendered, thrombotic, tick, timolol, Timoptic, UK, vast, viral, XE, Zontivity
Removed:
advance, affirmed, APP, appealed, bring, certify, conceded, conducted, dormant, enforceability, equal, esomeprazole, formal, Fze, Hanmi, Hetero, Indiana, Integrilin, interpretation, IVAX, jointly, Lupin, Marion, Millennium, Mylan, nonproprietary, notify, Parenteral, Pharma, President, Ranbaxy, Reddy, salt, stayed, suspend, thousand, Torrent, TPM
Valuein 2014 Q1 filing- Value in 2014 Q2 filing
Original filings
Filing view